0001193125-12-491686.txt : 20130111 0001193125-12-491686.hdr.sgml : 20130111 20121205115123 ACCESSION NUMBER: 0001193125-12-491686 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20121205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Theratechnologies Inc. CENTRAL INDEX KEY: 0001512717 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2310 ALFRED-NOBEL BLVD. CITY: MONTREAL STATE: A8 ZIP: H4S 2B4 BUSINESS PHONE: 514-336-7800 MAIL ADDRESS: STREET 1: 2310 ALFRED-NOBEL BLVD. CITY: MONTREAL STATE: A8 ZIP: H4S 2B4 CORRESP 1 filename1.htm Corresp

 

LOGO

VIA EDGAR

December 5, 2012

Mr. Frank Wyman

Staff Accountant

United States Securities and Exchange Commission

Division of Corporate Finance

Washington, D.C. 20549

United States of America

 

Re: Theratechnologies Inc. – Form 40-F for Fiscal Year Ended November 30, 2011 – Your File No.: 001-35203

 

Mr. Wyman,

Reference is hereby made to our telephone conversation of November 5, 2012 during which we agreed to provide you with proposed additional disclosure under Significant Accounting Policies - Note 3(g) - Inventories appearing in our audited consolidated financial statements for the year ended November 30, 2011.

During this conversation, we agreed that the proposed additional disclosure would be prospective.


LOGO

Therefore, based on the facts that existed on the date of our audited consolidated financial statements for the fiscal year ended November 30, 2011 and assuming that these facts remain the same for the preparation of our audited consolidated financial statements for the fiscal year ended November 30, 2012, we propose the following disclosure under Significant Accounting Policies - Note 3(g) – Inventories:

Inventories are presented at the lower of cost, determined using the first-in first-out method, or net realizable value. Inventory costs include the purchase price and other costs directly related to the acquisition of materials, and other costs incurred in bringing the inventories to their present location and condition. The company is responsible for coordinating the production and the stability testing and for auditing suppliers at different time during the manufacturing process. Inventory costs also include the costs directly related to the conversion of materials to finished goods. Net realizable value is the estimated selling price in the Company’s ordinary course of business, less the estimated costs of completion and selling expenses.

Work in progress inventory appears from the moment third-party suppliers use the material provided by the Company until the time the Company receives the finished product. The value of the work in progress is equal to the value of material provided by the Company plus all other work performed by third-party suppliers which has been invoiced to us.

We also propose the following disclosure under Significant Accounting Policies - Note 3(d) – Cost of sales:

Cost of sales represents the cost of goods sold and includes the cost of raw materials, supplies, direct labour, direct overhead charges, unallocated indirect costs related to production as well as write-down of inventories.

We trust the whole to be to your entire satisfaction and remain,

Yours truly,

THERATECHNOLOGIES INC.

/s/ Marie-Noël Colussi

Marie-Noël Colussi

Vice President, Finance

GRAPHIC 2 g449259img01.jpg GRAPHIC begin 644 g449259img01.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`)P!W`P$1``(1`0,1`?_$`*(```$$`@,!```````` M```````&!PD*!0@!`P0"`0`"`@,!`0```````````````@,&!`4(`0<0```' M``$$`0(%`0D!``````$"`P0%!@<(`!$3"1(4%2$Q(A87&$%1,C.UU997=SD1 M``$#`@,$!@<'`P4```````$1`@,`!"$2!3%!41-A(C(4!@=Q@9&Q4A4(\*'! MT4(C,_%R4Y+2-18V_]H`#`,!``(1`Q$`/P"??G)[I+;Q)YPUSBY"X1'7"HM# MYN2Z3\E,RK&WSO\`(IVBB0YTP:MS1JA8IL^(F47)7'UCU-1$OB^/RZKU_K;[ M.^%JV,&,(IQ4K\/VVUUYY6?3+IWF%Y63>/+G5GVVHN%SR8VL8Z&/NZKWAQ.; MKEI/5RY&%KCF5*Y9>Z6UNO9NOP@-@K4N>DU)]C2=G))RQM*_<3!FN#6WG4^Y1H\ MT1JSOG)L&WABRL[MRW$?LYUS\T`IF7+S%9EWTW?&3WQVC;=EY"4FR<;PCJGF M65;5JM-3JDO*R%V%IC3)U).("]MGC0T>U?6%NV\(+MDTB,GA@2,FJ`_,([77 MWSS2,=$C&LKN/I^ZMQXX^DZP\,>&M'U2RUK/J%]J%E:S.#1) M`6G,6QDKE<27LZP+=E;+>ICVL7'V(SNQU6\Y'!4"4SB.K]FBIFF2DM+UQ[!V M)\_8(0TLK+D%9O8VBC+R%.F<$G:/S,5)+QB!LK2-6DU%SV2,#2T`J-B'<5WU M2?J#\@=-\F[33=0TK49;N"]?)$]DS6,D:^-K7%[`S`QD%""%8Y`7.7":[K>5 MS#1T45BY>;A:\R-)3\O%P<<11-([^7D&D:R*JL;XI)&=/544"J*F_`I1-W,/ MY=*Y[6#,\@-Z<*9K7/*-!)Z*2G\L99_V50/^95W_`''J/O%O_D9_J'YT_(G^ M!_L-**#M%9LZ;A6M6*"L*30Z:;M2#EX^63:J*E$Z2;@[!PX*@=0A1$H&["(! MW#IV21R8L<'`<"M(YCV=L$>D)6=Z>EHZ**.BBCHHHZ**.BBFWLF.9)<;C6=# MMN8T"S7VF=AJ5SGJC`RUHK7Q4,L3[).OV"\G&^%QA$>HGP M0R/$CV-,C=A(!(]!K=67B3Q#INFSZ-I]]=P:3<_RPQS2,BDW=>-K@URC`J"H MP.%5PF',GDP?W=O\H_I>S/[&%ZD&+E,3,6]GK9?BS;=F/!,*[2F\M?`X^EUGB#Y M[?=Z[HVYR=]<;7O9>%M.Y9N7F:XEF#>;G',5,*^O5GS!Y';-[$-_S[1N,&74 M.!L3#0'NCR=4P^/H5LSY_7Y@B$'#WB[H1Z$I7,^I21R1,:TYLR,0A-@)WKLQV[://GRY\%^&O)S2-8T;7;^[NX7VXMFR MWSIXKALC%>^"`N+8>6.L#$&AC>H[$BK'^>9%E61M9=CE>;47.&4_)*3,VTHU M4@ZJWEY53Y`:0D481BR3>.@`X@4Z@&$I1[!V#\.K-%##""(6M:"<4`'NKBS6 M?$6O^(I(Y=?O;N]EA9D89Y7REC!^EI>YR#H&W?3B=2UIJ.BBF(Y&\=Z%RAS) MYD^D+V!O6'LQ#3:RM9D&T9*@\@G7U;(".W3"12*B*O\`C+XA$P?D(=8MY9Q7 MT!MYER$@X8'#VUDVEU)9S<^),Z$8[,:KMZQP`PND>P+!^+T.[O2F<:74C3EB M=/IV/7M"3TK6\K`6,E20B+9J@)ZVW_29LH/8Q_Q_$.U/N-)M8M6BL6YN2]JG M$+^K84Z.%6F#4[B33)+QP;S6.088;MN/36[:$)!>M+DEQ^PG#G0&S?D_93R& MLRNH/4IB5BTJJ9&+:.*_,,@KD?"MR,I)4RPN47!1,`#W*'5NBWL5K:G] MB=RO+L2$PP."5KLSM7M);BX'[L+>J&X#'B,5V5+W3M?RC1'KV-H.ET*Z2,;\ MQ?L*K;8&>>LRD,!#J.&L8^_X=^K#'<6\Q+8GL<1P(/NK1R0 M3Q!96.:#Q!%+25EXF!8.)6/%46Z)!,/;N M8P!WZD0&\3A4;6N<BD3%[%D4Y(LX>$U/.)B6D5BMH^+B[Q69" M1?.#`)BH,V3246&C> MAI2V.WU.G-$W]NL]=JS%9044GMCFHV#:*J@'R%)-S)N6J)U`*/?X@81[=.^2 M.,+(X-'20/?2LC?(4C:7'H"UYY*]4B&A65DF+C58JNR2:*T=/R5AB&,*_2Q;J++JB`$ M22(8YA`H"((+JV=@)&$I\0W;=].;><8ECP/0?RIR^IZAJMY&V7VYC[AG$6[B M])_I2_D9XT/\ZZU+@H<>BLUCL7[>P_0E9&NPMP(?L#D909@3)F)X>Y>JR':O M\Y0A_=.2R_P"_]R!_D/?_`)@HS-,>;-R%4=GE MW&O<8EH;G,8XTKIK*AC'R M)S+U%F@W=R0@:=(T*]48I'>D;"/P[)BJ8-1K3KYMJ#8YL^;K9>TG1Z]J8UT! M].%MY7W7CM\?FB;8:=W1QMQ=.RVKI\S<)B2&_P`>?('D,+MN.44^'K7D>4DM MPZRE]S$;R[;;ED9S[H%F:(,+BM6R3;XE0JQ>?\`HK?^S\'U8;3_ M`(&?^_\`VTF?:;F4?M'+K@YD\N_=1<3H"]CKH/H44^C3&WLKF9H5S4/W&DISSX= M9-PFS6@\F^,!+!F6AYK?JG&**M[',RK:S,9,71%32Q91VZ$'"JK4I5R)_!LY M;*JIJ)"`E^,>JZ=;Z9"R]L59*QX&TE?2O]"*?3;^?4)7VEXCXGM)V##[>T4T MG/32[GO',&EY#8L_U'5,MJ>;4VZ(XGDDFXBYFW2=IJ+6U2LXHLG'RQUDHY21 M(U.L5NJH@V:G!(4S**'Z@U6:2[U!MN]CWPM8#D8<22%)W^[8*GTV&.VL'3M< MQDSGD9W!0`"@&[A[33F\2\:R=KR,RE_'^M_DGC$C%3[B6C].NMUN$A5ZF^C8 M>3=MGDNR?P+-FY1=*I`V(510I146+^?Y#-I]O;]\C(LIHR"N9SB@0;\/545] M//W1X-W#("$R@!3CNQ]=9+#\#K7LCY#C.\RSO.XN=>0\-" MQ;1Y+(HJ>5F8JZ)$F<:F8Q$!2%R[7556,;L4O36MHS6;N>>]+BR-^5K04`&/ MY>VEN+IVDVL,-F`'O;FSFS7BH]C,=Q_ M&&EF?1Y8:H03Z;K<4\<+E/\`<54VS2LE.Z73\:SQZ[`RR@E*1,4M+*+4[R:. MY+N3`0QC%1`%`]V/$G&GNKN73[6)]N&\Z97.>FTE"??Z@*YFN'6#Y'[+,:P> MCUF1C\YT[`M.:V^-=3\I(OGR-OINGU.<*UEG:QW[`'$(0$R^,X>,_PCUX M_3K6WUJ.UB:1"^)RA3O#@??88,M&Y/[W](.TQZ[[^#7,:NG'9D.'_>OOP`U042:=S1I8_YI M_7`Y^8@(U86FH?.^;S!R\R]K]'PY57HV)OKN"7Q]Y2GZ96:$-(D^?=V;`O5D2NSU@<5^=V6^PC>+KM^[0UPH\>WNS'0F3/;( M_0G>B3D_*%7IDBK0FLS(2E(/#?BX`9)G'*M"@+-(IB&,`>Z5:7\6HR/GD!8% MS=9U?S)%0EKP#,XJ M4L.8/($HJ/:Y.AH;!E._NA:=:(,D4COU3KD^D5%NFDF900*N0>M+-:Q3:NVY MY@$D3`2U-QS8JOMPP]=;:*YDBTMUORR62O(#EWC+@B?C[J4F\892-DWKC)R4 M#C'UK^=);7$EO;36G+<7R`<0GJ3\J[N3&>T/V`X;8,AI&M0 M]7>1E[!W+/5(U&F4D'!1OWT6DLNF7`GD87`MPW+F`(Q0^RD-R+X88]O]?SG4 M*]N`91I>40<7483>J-.19&2Z$(D#)./FE6\TQ2%5H_,H*!D9!!TV%=1(3G(; MX=17FFV]VQD[)>7-&``]IX<?:!(0:K%\X@W!S")%BD M*D4Q@[&`>H+:RN8KH&2\>]K`'%I5"TJF.9-U33W=O);$,M6L<\EH(100BX95 MWUL;Q(X^U;BJSVVX/-FJUOKNVZ@ZOK.;%.-KT+#'>+R@EA4Y=2Q2C&76*=V8 MH*%.B(BF/Z/[LW3[2.P$LID:YDK\RX`#;@JE:Q+VY?>&.,1N:Z-B)M)V8[`E M:_[WPWS+5]9M^_8GR,LO%O3&;V-KU\ND"N,=3[@^F*_%3;-ZT?%G*P1V[D89 MX@+A9H]5;.E$^YTA6(:<,<`3V@K2`1 MUEP7-4S]3C,'*CMTE-A1P)!&5,42IONK/5=JL,PX`54GN9=[N7GGQ_/+ M'UV4TL,8;:?"CR>++O(1RX/E)Z/]W%ZG!,F*_P``/V,8(4A2BU#\PJPT]OSK MG]XC7.79KG@+5<&Y_P"I:?$\[>/6Y/8N*TR/0SK*M-AK1K%B0LDZ@61D M]AK3.8=.8@]7>"7ZDO=V`RWP$3I=NQC2=/9;Z@Z47$4B!V#7`N*_$-R;^FE\ M^/-O4/%GE%8:%<>%-9TJ.22V<;BZMGQ6D9CC.5MG*Y@#^:U(YCHM\U9=;<<6SFQ6+):"RO+&TOZZSN,"VH=]3LU8 MDY5V,Y'2C'.KTE(_:II-TF4CDB#(4E#>/Q#I+^UAFED/-B8XQMS*0HRN4+B# ME,B5X;P,TV)![)"!1 MZ#:6[V%D4L(G64N((5'*H*%4:H5=B5X+J=KPZ6*4PI&&@@HK4V*$5R%$VK69 MN&0XL>>?Z7G&O<26N=M+K2U(3-;?(5E_ACZX-\QF:Q+(V&+AIQG#HW1S"O6D ME%J(D57!-L)U$C@8%2O);VVUW[2DV M>74>I1ELXS04XXHE/A7[>$C2W1LG7M":-(--ZJ^4`X*F?N_FW;E'RFQYVQ6[ M1.'0O+GNZK0#&#E`P&;!V"KTG`5-"9)W&'+*P-:WK$I(0I..&+<43H&)K&Q_ M&"KR.=9=99?D=@,++-XVK`%*LU]@%:5]:^PO-(9V@,FPEG;1Q:HEE7R.VBS= M%RDK$R'R*)2'*J;QMBPPL>Z:(.0=4N"=AHV@[0BC;@:9UX\2O8V*4M4X@%>V MX[QLQ0](I^*AB589[U-W"!V3BU'/'$#:D;/4(*T-+3-SKMSEIH8%)%A87#YU M2VS5OX)!XM%"@3[`7?OK_]D_ ` end